Skip to content

Main Navigation

Locate Bio

Menu

  • Home
  • Products
    • LDGraft™
    • CertOss™
    • OsteoMime™
  • We are LocateBio
  • News
  • Contact

Locate Bio: next-generation orthobiologics

  • Locate Bio
  • October 20, 2022
  • 1 Minute read

Next-generation orthobiologics

 

Lower back pain is the single leading cause of disability in 160 countries, according to the World Health Organization. It is often caused by degenerative disc disease, a progressive and irreversible condition that leads to a loss of disc height that can compress the spinal nerves and cause excruciating, intractable pain with devastating social consequences. Unfortunately, efforts to manage the condition—such as using strong painkillers including addictive opioids and performing spinal fusion surgery—are often inadequate. New and effective orthobiologic products are urgently required to address this significant unmet need.

A PDF copy of the full White Paper can be downloaded below.

Download PDF paper

You may also be interested in...
See all posts

News

First Participant Treated in Groundbreaking LDGraft RESTORE Study for Spinal Fusion

News

Locate Bio’s LDGraft Granted FDA Breakthrough Device Designation

Resources

Programmed Drug Release of rhBMP-2 for Bone Healing

Loading...

Choose your region

Please select where you are visiting from

USA Outside of USA

About LocateBio

LocateBio is an innovative UK MedTech company with industry-leading drug delivery and tissue scaffold capabilities.

Links

  • Contact

Legals

  • Privacy and Cookies
  • Cookie Policy

© 2026

  • USA